Secondary infarction in single or in multiple vascular territories: two different entities following subarachnoid hemorrhage? by de Rooij, N. K. et al.
ORIGINAL COMMUNICATION
Secondary infarction in single or in multiple vascular territories:
two different entities following subarachnoid hemorrhage?
N. K. de Rooij • C. J. M. Frijns • B. K. Velthuis •
G. J. E. Rinkel
Received: 28 January 2011/Revised: 14 April 2011/Accepted: 19 April 2011/Published online: 7 May 2011
 The Author(s) 2011. This article is published with open access at Springerlink.com
Abstract The pathogenesis of secondary infarctions (SI)
after aneurysmal subarachnoid hemorrhage (SAH) is
poorly understood. To assess whether SI in single (SSI) or
multiple (MSI) vascular territories represent different dis-
ease entities, we compared clinical proﬁles of patients with
these patterns of SI. CT/MRI-examinations of 448 patients
were reviewed for new infarctions within 28 days after
SAH, and categorized into SSI or MSI. Only patients with
adequate follow-up imaging excluding any new infarctions
were included for analysis (269 patients). Procedure-related
infarctions were excluded. Odds ratios (ORs) with corre-
sponding 95% conﬁdence intervals (CI) were calculated for
patients with SSI or MSI versus patients without SI to
analyze differences in demographic characteristics, vascu-
lar risk factors, disease-related characteristics and treat-
ment modalities. Thirty-six patients had SSI, 53 MSI and
180 no SI. ORs in MSI-patients were [1.5 times higher
compared with ORs in SSI-patients for multiple vascular
risk factors [MSI:5.4 (2.3–13) versus SSI:1.2 (0.5–2.8)],
poor clinical condition on admission [MSI:4.6 (2.4–8.9)
versus SSI:2.4 (1.1–5.2)], initial loss of consciousness
[MSI:2.6 (1.3–5.3) versus SSI:1.1 (0.5–2.3)] and large
amounts of intraventricular blood [MSI:2.9 (1.4–5.8)
versus SSI:1.5 (0.7–3.2)]. In multivariate analysis ORs
remained higher in MSI for presence of multiple vascular
risk factors [MSI:1.9 (1.2–2.9) versus SSI:1.1 (0.8–1.7)]
and initial loss of consciousness [MSI:3.0 (1.0–8.9) versus
SSI:1.6 (0.6–4.0)]. Our ﬁndings suggest that SSI and MSI
after SAH are not distinct disease entities. MSI was related
to the same characteristics as SSI but to a larger extent,
speciﬁcally to the presence of multiple vascular risk fac-
tors, initial loss of consciousness, larger amounts of intra-
ventricular blood, and poor clinical status on admission.
Keywords Delayed cerebral ischemia  Secondary
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Introduction
Delayed cerebral ischemia (DCI) is a major cause of poor
outcome after subarachnoid hemorrhage (SAH). Although
cerebral vasospasm has been indicated as the main cause of
DCI [13], vasospasm and DCI do not always go hand in
hand, which shows that vasospasm is not the only or
essential factor for the development of DCI [2, 3, 9]. Other
factors that may contribute to DCI besides large vessel
vasospasm are inﬂammatory processes, intracranial mi-
crothrombosis, cortical spreading depolarisations and
impaired cerebral autoregulation [4, 8, 14].
DCI may have several patterns. From a subdivision
based on number and sites of infarctions on cerebral
computed tomographic (CT) scans after SAH, two com-
mon patterns were distinguished [10]. These two common
patterns were on the one hand a single cortical infarct and
on the other multiple cortical and/or deep cerebral infarcts.
It is unclear whether these secondary infarct (SI) patterns
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different degrees of severity of the same vascular process.
We assessed whether secondary infarctions in single
(SSI) or multiple (MSI) vascular territories represent dif-
ferent disease entities by comparing the clinical proﬁles of
the patients with SSI or MSI with those of patients without
infarction. We analyzed demographic characteristics, vas-
cular risk factors, disease speciﬁc characteristics, and
treatment modalities as determinants for development of
SI.
Methods
Patients and data
From the prospectively collected database of all consecu-
tive patients with SAH admitted to the University Medical
Center Utrecht, we included all patients with an aneurys-
mal SAH who were admitted within 3 days after onset
between January 1999 and June 2007. The diagnosis of
SAH was based on a positive CT scan or xantochromia of
the cerebrospinal ﬂuid. Presence of an aneurysm had to be
conﬁrmed by means of CT, MR or catheter angiography.
For inclusion in the current study at least one follow-up
scan, performed more than 24 h after the initial CT scan,
was required.
For every patient we recorded data on gender, age,
current smoking, history of hypertension, previous car-
diovascular events (including stroke, myocardial infarction
and peripheral vascular disease), hypercholesterolemia,
diabetes mellitus, family history of cardiovascular events,
and use of salicylic acid and statins at the time of admis-
sion. The clinical condition on admission was assessed
with the World Federation of Neurological Surgeons scale
and dichotomized in good (WFNS I to III) or poor (IV or
V) [1]. We also recorded loss of consciousness at onset,
and modality and timing of intervention. All patients were
treated according to our standard protocol, including
absolute bed rest, compressive stockings, intensive moni-
toring on our medium or intensive care unit until aneurysm
treatment, nimodipine 360 mg daily orally, and intrave-
nous administration of ﬂuids aiming at normovolemia for
3 weeks.
Initial CT scans were evaluated for amount of blood,
hydrocephalus and pre-existing infarction. The amount of
cisternal and ventricular blood was assessed according to
the method described by Hijdra et al. [7] and dichotomized
at their median values. The presence of acute hydroceph-
alus was quantiﬁed and adjusted for age by means of the
bicaudate index (BCI) divided by the corresponding upper
limit per age group [6]. Acute hydrocephalus was deﬁned
as an age-adjusted relative BCI of[1.
Follow-up scans were evaluated for new ischemic
lesions. Lesions caused by extraventricular drains, pre-
existing infarcts and hypodensities around a hematoma or
in the vicinity of the operation area were not considered
new infarctions. Only infarctions unrelated to angiography
or aneurysm treatment were deﬁned as ‘‘spontaneous
infarction’’. Infarctions were considered to be related to
treatment if new neurological symptoms occurred directly
after aneurysm treatment, and an infarct was visible in the
territory of the parent vessel of the aneurysm on CT within
48 h after treatment. In case the time of development of
infarction was uncertain (for example if a new infarction
was present on CT [48 h after treatment and/or the neu-
rological state of the patient directly after treatment could
not be assessed due to sedative medication), an expert
opinion was made by two of the authors, who were not
aware of the risk factor proﬁle. In this expert opinion the
report of the operation or endovascular treatment was taken
into account. In case of disagreement, the infarction was
not counted as spontaneous infarction. To investigate if
differentiation between edema and infarction could reliably
be made in the presence of an intracerebral hematoma
(ICH), we performed an interobserver study between three
observers (two senior neurologists and one senior radiol-
ogist) in 25 patients with an additional ICH and a sur-
rounding hypodensity. This study showed a large
interobserver variability with kappa values around 0.50
(95%CI 0.06–0.96). Since subdivision in SSI and MSI in
these cases could not reliably be made, patients with an
ICH and a surrounding hypodensity were excluded.
The location(s) of spontaneous infarctions were deter-
mined by using validated arterial territory maps [11, 12].
We only included infarctions that developed within
28 days after SAH and were conﬁrmed on a late follow-up
scan. SSI was deﬁned as infarction in one arterial territory
and MSI as infarctions in more than one territory. Adequate
follow-up (late CT or MRI follow-up between 28 days and
6 months after SAH) is necessary because within the ﬁrst
28 days SSI could develop into MSI, and NSI could
develop into SSI or MSI. Because new (silent) infarctions
in other territories had to be excluded for a valid subdivi-
sion, we excluded patients with a single infarction or
without any infarction who had no late follow-up scan.
All scans were reviewed for presence or absence of
hypodensities by one author (NKdR). The ﬁrst 35 scans
were also reviewed independently by a senior vascular
neurologist (CJMF). No disagreement was noticed with
respect to presence or absence of hypodensities. All scans
with hypodensities were independently reviewed and sub-
divided into SSI and MSI by NKdR and CJMF. In case of
disagreement, consensus was reached in a meeting of all
authors, including another senior vascular neurologist and a
senior radiologist.
2134 J Neurol (2011) 258:2133–2139
123Data analysis
All patients with adequate radiological follow-up (SSI,
MSI and NSI) were included for analysis. Odds ratios
(ORs) for MSI or SSI compared with NSI were calculated
with corresponding 95% conﬁdence intervals (CI) using
univariate logistic regression. We decided to perform an
indirect comparison between MSI and SSI as primary
analysis to increase the statistical power of the study.
Furthermore, an indirect comparison reveals both the rel-
ative differences in ORs between MSI and SSI, and the
absolute ORs for MSI and SSI separately. Additionally, we
performed a direct comparison. All patient speciﬁc risk
factors and disease speciﬁc characteristics were analyzed,
except for the risk factors found in less than 10% of the
patients. The total number of the vascular risk factors was
analyzed as well: age above the median value, male gen-
der, hypertension, previous cardiovascular disease, positive
family history of vascular disease and current smoking. We
deﬁned high number of vascular risk factors as any number
above the median number. Multivariate logistic regression
was performed with all variables of which the association
with MSI was more than 1.5 times higher or lower than the
association with SSI.
Results
Of 828 consecutive patients with aneurysmal SAH admit-
ted to our hospital within 3 days after onset of the
hemorrhage during the study period, we excluded 222
patients with incomplete scans. In 182 of these 222 patients
no follow-up scan was made because of good outcome
(n = 65), transfer to another hospital (n = 7), or early
death (n = 110), and in 40 patients the initial or follow-up
CT scan could not be retrieved. We excluded 149 patients
because a large ICH with a surrounding hypodensity was
present and subdivision in SSI and MSI could not reliably
be made. Nine patients, in whom no consensus for presence
or timing of infarction could be reached, were also exclu-
ded. An infarction related to treatment was recorded in 76
patients (17%). Eighty-nine of the 269 included patients
with adequate follow-up developed spontaneous infarc-
tions: 36 patients in a single vascular territory and 53
patients in multiple territories. In 180 patients no infarction
was present (Fig. 1).
Baseline characteristics of these 269 patients are pre-
sented in Table 1. The median number of vascular risk
factors was two. History of hypercholesterolemia, diabetes
mellitus, use of salicylic acid and use of statins were
recorded in less than 10% of patients, and were not used in
the analyses.
Results of the indirect comparison (patients with MSI
or SSI vs. NSI) are shown in Table 2. ORs were C1.5 for
both MSI and SSI in ﬁve characteristics: positive family
history of cardiovascular events, smoking, poor WFNS,
and high amount of both cisternal and ventricular blood.
The association with MSI was more than 1.5 times
stronger than with SSI in eight characteristics: male
gender, high age, history of cardiovascular events,
Consecutive SAH patients
n = 828
Exclusion: no follow up CT or MR available for review n = 222
Spontaneous SI
n = 111 ( 24%)
Multiple SI 
n =  53
Exclusion: large intracerebral hemorrhage n = 149
Patients fulfilling inclusion criteria    
n = 457 
Exclusion: no consensus about presence infarction n = 2
Exclusion: uncertain if infarction was present within 28 days n = 7
Treatment related infarctions were excluded *
Probable Single SI 
† n =  22
Single SI
n =  36
No SI 
n = 337 ( 76%)
Probable No SI 
† n = 157
No SI 
n =  180
Patients for analysis
n = 448
Consecutive SAH patients
n = 828
Exclusion: no follow up CT or MR available for review n = 222
Spontaneous SI
n = 111 ( 24%)
Multiple SI 
n =  53
Exclusion: large intracerebral hemorrhage n = 149
Patients fulfilling inclusion criteria    
n = 457 
Exclusion: no consensus about presence infarction n = 2
Exclusion: uncertain if infarction was present within 28 days n = 7
Treatment related infarctions were excluded *
Probable Single SI 
† n =  22
Single SI
n =  36
No SI 
n = 337 ( 76%)
Probable No SI 
† n = 157
No SI 
n =  180
Patients for analysis
n = 448
Fig. 1 Selection of patients
with spontaneous single and
multiple secondary infarction
(SI) within 28 days after
subarachnoid hemorrhage
(SAH). *All treatment related
infarctions were excluded.
Depending on the presence or
absence of other infarctions
these patients were included in
the SSI, MSI or the NSI group.
All gray marked patients had
adequate radiological follow-up
(late follow-up scan between
28 days and 6 months after
onset of the SAH) and were
included for analyses. SSI and
NSI were deﬁned as probable if
there was no late CT or MRI
follow-up to exclude new
infarctions in other territories
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123presence of [2 vascular risk factors (including these
former three variables), poor WFNS, initial loss of con-
sciousness and high amount of ventricular blood. There
were no factors of which the association with SSI was
more than 1.5 times stronger than with MSI. In the
multivariate analysis the association with MSI remained
statistically signiﬁcant for initial loss of consciousness
(OR 3.0; 95% CI 1.0–8.9) and presence of [2 vascular
risk factors (OR 1.9; 1.2–2.9) (Table 3).
In the direct comparison (MSI vs. SSI) we found
essentially the same associations, however with wider
95%CIs because of the smaller numbers of patients. Two
associations reached statistical signiﬁcance in the univari-
ate analysis: presence of[2 vascular risk factors (OR 4.7;
1.5–14) and any loss of consciousness at onset (OR 2.5;
1.0–6.5). In the multivariate analysis of the direct com-
parison the presence of[2 vascular risk factors remained
signiﬁcantly associated with MSI (OR 1.8; 1.0–3.1).
Table 1 Baseline characteristics of 269 included patients
Number of
patients
a
No secondary
infarction (N = 180)
Single secondary
infarction (N = 36)
Multiple secondary
infarction (N = 53)
Patient characteristics
Women (%) 269 129 (72) 26 (72) 33 (62)
Median age in years (range) 269 54 (18–83) 51 (26–76) 54 (29–77)
Hypertension (%) 263 43 (24) 8 (30) 14 (29)
History of cardiovascular events (%) 264 26 (15) 3 (9) 8 (16)
Family history of cardiovascular disease (%)
b 269 26 (14) 9 (25) 9 (17)
Diabetes (%) 263 9 (5) 0 (0) 3 (6)
Hypercholesterolemia (%)
b 269 7 (4) 3 (8) 3 (6)
Current smoking (%) 204 80 (54) 20 (67) 18 (67)
Use of salicylic acid (%) 247 12 (7) 5 (15) 6 (14)
Use of statins (%) 259 13 (7) 3 (8) 4 (9)
SAH characteristics
Poor WFNS (IV, V) on admission (%) 268 37 (21) 14 (39) 29 (55)
Any loss of consciousness at onset (%) 239 61 (37) 12 (39) 27 (61)
Median amount of blood on initial CT
Cisternal blood (range 0–30) 163 24 (0–30) 26 (0–30) 26 (0–30)
Intraventricular blood (0–12) 141 2 (0–12) 2 (0–8) 3.5 (0–12)
Acute hydrocephalus
c (%) 49 (41) 15 (50) 22 (50)
External ventricular drainage 261 56 (33) 16 (44) 19 (36)
Site of the aneurysm (%) 269
Posterior communicating artery 35 (19) 10 (28) 13 (25)
Internal carotid artery 6 (3) 1 (3) 5 (10)
Middle cerebral artery 23 (13) 9 (25) 4 (8)
Anterior communicating artery 77 (43) 9 (25) 20 (38)
Pericallosal artery 9 (5) 0 (0) 1 (2)
Basilar artery 13 (7) 3 (8) 2 (4)
Vertebral artery 12 (7) 1 (3) 4 (8)
Other 5 (3) 3 (8) 4 (8)
Treatment of the aneurysm (%) 269
No treatment 23 4 (2) 0 (0) 19 (36)
Coiling 108 75 (42) 16 (44) 17 (32)
Clipping 138 101 (56) 20 (56) 17 (32)
Poor Outcome (GOS 1 or 2) at discharge (%) 256 2 (1) 2 (6) 28 (60)
WFNS World Federation of Neurological Surgeons Scale, GOS Glasgow Outcome Scale
a Number of patients is\269 in case of unknown data
b These risk factors were recorded as present if they were mentioned as present in patient’s history, otherwise as absent or unknown
c Acute hydrocephalus was deﬁned as an age-adjusted relative BCI of[1
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Our study showed that all patients with secondary infarc-
tion had a similar clinical proﬁle. Both infarct patterns
(single or multiple vascular territories) were related to
characteristics representing poor initial condition after
SAH and presence of vascular risk factors when compared
with patients without infarction. However, patients with
MSI had an obviously stronger association with these risk
factors than patients with SSI, with odds ratios being higher
for MSI than for SSI regarding the presence of multiple
vascular risk factors, poor neurological condition on
admission, initial loss of consciousness, and large amounts
of intraventricular blood. These results suggest that SSI and
MSI after SAH are not distinct disease entities, but con-
sequences of increasing severity of the same risk factors,
and therefore different degrees of the same pathophysio-
logical process.
A previous study distinguished ﬁve distribution patterns
of infarctions after SAH (based on location and number of
infarctions) and analyzed factors that determined their
occurrence. The authors suggested that single cortical or
multiple cortical and/or deep infarctions are two common
types of SI, and may represent different pathophysiological
Table 2 Differences in clinical and radiological data between patients with single and multiple secondary infarctions (SI) compared with
patients without SI
Number of
patients
OR (95% CI) single SI
(n = 36) vs. no SI (n = 180)
OR (95% CI) multiple SI
(n = 53) vs. no SI (n = 180)
Patient characteristics
Male gender 269 1.0 (0.4–2.2) 1.5 (0.8–2.9)
Age C54 years (median) 269 0.5 (0.2–1.1) 1.0 (0.6–1.9)
History of cardiovascular disease 264 0.5 (0.2–1.9) 1.1 (0.5–2.7)
History of hypertension 263 0.9 (0.4–2.2) 1.3 (0.6–2.6)
Family history of cardiovascular events 269 2.0 (0.8–4.7) 1.5 (0.9–2.5)
Current Smoking 204 1.7 (0.7–3.8) 1.7 (0.7–4.0)
More than two vascular risk factors
a,b 203 1.2 (0.5–2.8) 5.4 (2.3–13)
SAH characteristics
Poor WFNS (IV or V)
b 268 2.4 (1.1–5.2) 4.6 (2.4–8.9)
Any loss of consciousness at onset
b 239 1.1 (0.5–2.3) 2.6 (1.3–5.3)
Amount of cisternal blood C25 (median) 224 2.1 (1.0–4.5) 1.5 (0.8–2.9)
Amount of ventricular blood C2 (median)
b 219 1.5 (0.7–3.2) 2.9 (1.4–5.8)
Acute hydrocephalus 194 1.4 (0.6–3.2) 1.4 (0.7–2.9)
External ventricular drainage 261 1.7 (0.8–3.4) 1.2 (0.6–2.2)
Clipping vs. coiling of the aneurysm 246 0.9 (0.5–1.9) 0.7 (0.4–1.6)
a Number of following six risk factors: age above the median value, male gender, hypertension, previous cardiovascular disease, positive family
history of vascular disease and current smoking. High number of vascular risk factors was deﬁned as any number above the median (two)
b Factors in multivariate analyses
WFNS World Federation of Neurological Surgeons Scale
Table 3 Multivariate analysis of associations of patients’ and SAH characteristics with single or multiple secondary infarctions (SI) compared
with patients without SI
Number of
patients
OR (95% CI) single SI
(n = 36) vs. no SI (n = 180)
OR (95% CI) multiple SI
(n = 53) vs. no SI (n = 180)
More than two vascular risk factors
a 203 1.1 (0.8–1.7) 1.9 (1.2–2.9)
Poor WFNS (IV or V) 268 2.1 (0.8–5.6) 1.8 (0.5–5.9)
Any loss of consciousness at onset 239 1.6 (0.6–4.0) 3.0 (1.0–8.9)
Amount of ventricular blood C2 (median) 219 1.0 (0.8–1.2) 1.1 (0.9–1.3)
WFNS World Federation of Neurological Surgeons Scale
a Number of the following six risk factors: age above the median value, male gender, hypertension, previous cardiovascular disease, positive
family history of vascular disease and current smoking. High number of vascular risk factors was deﬁned as any number above the median
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123mechanisms [10]. That conclusion was based on associa-
tions of occurrence of multiple infarctions with history of
diabetes, early hydrocephalus and requirement of external
ventricular drainage (univariate analysis). Requirement of
external ventricular drainage was the only independent
predictor in their multivariate analysis. In contrast to our
methods, this previous study investigated a small popula-
tion of 56 patients, directly comparing patients with SI in
single or multiple vascular territories, without excluding
treatment related infarctions and with limited CT follow-up
time. Trends found for associations of multiple infarctions
with higher age, poor clinical condition on admission and
presence of vascular risk factors corresponded with our
ﬁndings. Because of the limited statistical power with 56
patients, relevant factors such as initial WFNS score may
have been undetected. To reduce this risk of type II error,
we made an indirect comparison that included 269 patients.
In our study acute hydrocephalus was assessed as BCI
adjusted for age, which we feel is a more accurate measure
than BCI alone, and found no strong association between
MSI and hydrocephalus. The factors that proved to be the
most important determinants in our study (presence of
initial loss of consciousness and presence of multiple
vascular risk factors) were not studied in the previous
study.
We studied a large population of 269 SAH patients, 89
of whom developed spontaneous infarctions after SAH.
One of the strengths of our study is the meticulous elimi-
nation of possible sources of confounding data due to
equivocal assessment of spontaneous SI. All CT scans were
independently reviewed by two authors and a specialist
team in case of disagreement. We performed an interob-
server study of the assessment of hypodense lesions at the
location of intracerebral hematomas. Because distinction
between perihematomal edema and (hemorrhagic) infarc-
tion proved difﬁcult to make, we excluded patients with
ICH and surrounding hypodense lesions in the comparison
between patients with SSI and MSI. For similar reasons we
also excluded patients with hypodensities in the operation
ﬁeld. In a study on pathogenesis of DCI, it is essential to
include only infarctions of which it is completely sure that
they are unrelated to a procedure. For that reason we
considered infarction as procedure related, if there was a
chance, not only if it was proven to be procedure related.
For analysis we included only patients with adequate
radiological follow-up. The disadvantage of this elimina-
tion of several sources of bias is that we had to exclude
large numbers of patients. However, because the original
sample we studied was very large, we were still able to
perform sound multivariate analyses.
As this was a retrospective study, we had some missing
data on the characteristics studied. Also, there was no
prospective protocol for standardized CT scanning at
predetermined time points and patients had scans at vary-
ing time points during their stay in our hospital. Since we
analyzed two radiological patterns of SI, clinical symptoms
of secondary ischemia without an infarct on CT or MRI
were not taken into account. MRI was not performed in the
acute phase of SI and was performed only in a minority of
our patients for follow-up of endovascular treatment of the
aneurysms. Follow-up by MRI was mainly performed in
patients without infarction, and more in SSI than in MSI.
Therefore, the fact that MRI is more sensitive is not likely
to have biased our results.
Previous literature found that focal or diffuse distribu-
tion of vasospasm by TCD or angiogram failed to reliably
predict the subsequent pattern of brain infarction [10]. The
aim of our study was not to assess the relation between
vasospasm and infarction, but to investigate the existence
of two different entities of SI. We deﬁned SI on non-
contrast CT or MRI and had no full information on pres-
ence or absence of vasospasm in all patients. Though
vasospasm may contribute to the development of SI,
infarction and vasospasm do not always go hand in hand.
Obviously, in observational studies SI is a more important
outcome event than the presence of arterial spasm by
angiography or TCD [5, 15]. Our data give no information
whether generalized vasospasm was more present in
patients with MSI, or focal vasospasm in patients with SSI.
However, other authors found no differences in occurrence
or extent of vasospasm in patients with different single or
widespread infarct patterns [10]. Therefore, we feel that
this is not an important shortcoming of our study.
In this study the presence of more than two vascular risk
factors was associated with development of SI. We could
not ﬁnd previous studies with similar ﬁndings. Since the
relationship between vascular risk factors and SI was not
the primary aim of the current study, no deﬁnitive con-
clusions can be drawn from this ﬁnding. Future studies
should focus on the identiﬁcation of additional clinical risk
factors of SI and unravel the association between vascular
risk factors and SI after SAH. Identiﬁcation of risk factors
may improve our understanding of the pathogenesis of SI
and help to tailor preventive treatment to the risk proﬁle of
individual patients.
In conclusion, our ﬁndings suggest that SSI and MSI do
not represent two different disease entities. We found that
MSI is related to the same characteristics as SSI but to a
larger extent, speciﬁcally to presence of multiple vascular
risk factors, initial loss of consciousness, larger amounts of
intraventricular blood and poor clinical status on admis-
sion. Our results underline the importance of clinical risk
factors for occurrence and extent of secondary infarction
after SAH.
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